Information  X 
Enter a valid email address

JPMorgan Global E.M. (JEMI)


Thursday 25 November, 2021

JPMorgan Global E.M.

Result of AGM

RNS Number : 6536T
JPMorgan Global Emerging Mkts I.T.
25 November 2021







Legal Entity Identifier: 549300OPJXU72JMCYU09

Information disclosed in accordance with LR 9.6.18


Following the Annual General Meeting of the Company, which was held today, the Board is pleased to announce that all of the ordinary resolutions put to shareholders were voted on by Poll and passed. The following special business was also voted on by poll and passed   which :

i.)  will allow the Company to allot new shares up to an aggregate nominal amount of £297,240, representing 10% of the Company's issued Ordinary share capital;


ii.)  will allow the disapplication of pre-emption rights on the allotment of new Ordinary shares and by way of a sale of Treasury shares;


iii.)  will allow the Company to make market purchases of up to 44,556,300 Ordinary shares representing 14.99% of the Company's issued share capital;


v.)  will allow the Company to continue to pay four quarterly interim dividends during the year.


vi.)  allows the Company to continue in existence as an investment trust for a further three year period from the date of the AGM.


vii.)  will allow the adoption of new Articles of Association of the Company.

The full text of all the resolutions can be found in the Notice of Annual General Meeting contained in the  2021 Annual Report and Financial Statements which is available for viewing at the National Storage Mechanism which can be located at and from the Company's website,    

The full results of the poll conducted at today's meeting will shortly be available on the Company's website,  


25th November 2021


For further information, please contact:


Divya Amin

For and on behalf of

JPMorgan Funds Limited - Secretary

020 7742 4000


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t